BlackRock’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,109
Closed -$8K 5980
2022
Q2
$8K Hold
1,109
﹤0.01% 5648
2022
Q1
$9K Buy
+1,109
New +$10K ﹤0.01% 5645
2021
Q4
Sell
-154
Closed -$2K 5894
2021
Q3
$2K Buy
+154
New +$1.74K ﹤0.01% 5557

Other funds holding AMYT

BlackRock's AMYT Position: Q3 2022 in Review

BlackRock sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q3 2022, closing a stake of 1,109 shares — an estimated $8K sold.

BlackRock first reported a position in AMYT in Q3 2021 and held it in 3 quarters. The position peaked at $9K in Q1 2022. 62 funds tracked by Wall St. Rank hold AMYT as of Q3 2022.

  • BlackRock reported no remaining Amryt Pharma plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • BlackRock sold 1,109 Amryt Pharma plc American Depositary Shares shares in Q3 2022, an estimated $8K.
  • BlackRock first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • BlackRock's Amryt Pharma plc American Depositary Shares position peaked at $9K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q3 2022.

Based on BlackRock's 13F filing for Q3 2022, filed 14 Nov 2022.